GOLEMBIEWSKI MICHAEL JOSEPH (Chief Financial Officer) purchased 2405.8% of their position (83K shares) of SEELOS THERAPEUTICS, INC. on the open market
Open‑market purchase worth $100.2K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 12/1/2023ACC: 0001104659-23-122841
Officer· Chief Financial Officer
Since Sep 2021
+83K
Net shares
Net buyer
$100.2K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
83K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+83K
Price / share
$1.21
Trade value
$100.22K
% of position
2405.8%
11/30/2023
3.45K→86.45K
Total
Net shares
+83K
Net value
$100.22K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/30/2023 | P · Purchase | +83K | $1.21 | $100.22K | 2405.8% | 3.45K | 86.45K |
| Total | +83K | $100.22K | ||||||
Derivative Transactions0
No derivative transactions reported